-
-
-
-
-
-
-
Class of 411014
-
-
-
Πρόσφατες ενημερώσεις
-
Huntington’s Disease Treatment Market Size, Unleashing Growth Potential and Forecasted Outlook for 2024-2031The Huntington’s Disease Treatment Market is experiencing a remarkable growth trajectory, with market valuation estimated at USD 468.44 million in 2023 and projected to soar to USD 2487.85 million by 2031. This substantial growth, reflecting a compound annual growth rate (CAGR) of approximately 23.21% from 2024 to 2031, underscores the increasing demand and advancements in...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 ΠροεπισκόπησηΠαρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Huntington’s Disease Treatment Market Size, Evaluating Share, Trends, and Growth Forecast for 2024-2031The Huntington’s Disease Treatment Market is experiencing a remarkable growth trajectory, with market valuation estimated at USD 468.44 million in 2023 and projected to soar to USD 2487.85 million by 2031. This substantial growth, reflecting a compound annual growth rate (CAGR) of approximately 23.21% from 2024 to 2031, underscores the increasing demand and advancements in...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
-
Fibromyalgia Treatment Market Size, Exploring the Forecasted Growth and Trends for 2024-2031The global fibromyalgia treatment market, valued at USD 3.32 billion in 2023, is projected to grow to USD 4.51 billion by 2031, at a compound annual growth rate (CAGR) of 3.9% during the forecast period from 2024 to 2031. This growth is driven by an increasing prevalence of fibromyalgia, advancements in treatment options, and a growing awareness of the condition. Key Players Some...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
-
Fibromyalgia Treatment Market Size, Forecasting Trends and Growth Opportunities from 2024-2031The global fibromyalgia treatment market, valued at USD 3.32 billion in 2023, is projected to grow to USD 4.51 billion by 2031, at a compound annual growth rate (CAGR) of 3.9% during the forecast period from 2024 to 2031. This growth is driven by an increasing prevalence of fibromyalgia, advancements in treatment options, and a growing awareness of the condition. Key Players Some...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
-
Hemostats Market by Manufacturers, Regions, Type and ApplicationThe global hemostats market, valued at $2.6 billion in 2022, is projected to achieve significant growth, reaching $4.11 billion by 2030. This expansion is expected to occur at a compound annual growth rate (CAGR) of 5.9% during the forecast period from 2023 to 2030. Key Players The major players are C.R Bard, Baxter, Teleflex Incorporated, Ethicon, Medtronic Plc,...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
-
Hemostats Market Size, Unleashing Growth Potential and Forecasted Outlook for 2024-2031The global hemostats market, valued at $2.6 billion in 2022, is projected to achieve significant growth, reaching $4.11 billion by 2030. This expansion is expected to occur at a compound annual growth rate (CAGR) of 5.9% during the forecast period from 2023 to 2030. Key Players The major players are C.R Bard, Baxter, Teleflex Incorporated, Ethicon, Medtronic Plc,...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
-
Central Nervous System (CNS) Treatment Market: Unraveling Growth Prospects and Trends till 2031The global central nervous system (CNS) treatment market, valued at USD 97.20 billion in 2022, is poised to grow to USD 196.53 billion by 2030, expanding at a robust CAGR of 9.2% during the forecast period from 2023 to 2030. This significant growth is driven by advancements in neuroscience, increasing prevalence of neurological disorders, and expanding geriatric population worldwide. Key...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
-
Central Nervous System (CNS) Treatment Market Size, Evaluating Share, Trends, and Emerging Growth for 2024-2031The global central nervous system (CNS) treatment market, valued at USD 97.20 billion in 2022, is poised to grow to USD 196.53 billion by 2030, expanding at a robust CAGR of 9.2% during the forecast period from 2023 to 2030. This significant growth is driven by advancements in neuroscience, increasing prevalence of neurological disorders, and expanding geriatric population worldwide. Key...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
-
Immunomodulators Market Size, Embracing Growth Opportunities in 2024-2031The global immunomodulators market, valued at USD 224.17 billion in 2023, is projected to expand to USD 368.23 billion by 2031, registering a steady CAGR of 6.4% during the forecast period from 2024 to 2031. This growth trajectory is driven by increasing prevalence of autoimmune diseases, advancements in biotechnology and pharmaceutical sectors, and rising investments in research and...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
-
Immunomodulators Market Size, Share Projections for 2024-2031The global immunomodulators market, valued at USD 224.17 billion in 2023, is projected to expand to USD 368.23 billion by 2031, registering a steady CAGR of 6.4% during the forecast period from 2024 to 2031. This growth trajectory is driven by increasing prevalence of autoimmune diseases, advancements in biotechnology and pharmaceutical sectors, and rising investments in research and...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
και άλλες ιστορίες
Προωθημένο